Neuro losing Strattera this Friday...

Quote












Anonymous said:
Just heard Strattera is getting pulled from Neuro bag end of this month. Anyone else heard the same. Did we lose appeal?
Click to expand...
Primary Care Reps should have it pulled. We should have a specialty rep calling on high writters in PC and Pedi offices. In fact, that person should cover high Psych customers. Think about it... 400 dollars to make a call and if you were a business owner you would not let us call on these useless pedi's.even if they are an easy call and are the only customers who will see us.
 
























Anonymous said:
Just heard Strattera is getting pulled from Neuro bag end of this month. Anyone else heard the same. Did we lose appeal?
Click to expand...

In a report published by Jefferies (JEF), Eli Lilly's (NYSE: LLY) Strattera appeal could be an uphill task.

Jefferies said that its analysis of the legal issues surrounding the Strattera US patent challenge appeal hearing suggests that the lower court's invalidity ruling is unlikely to be overturned, which could cause management to lower its guidance for 2011. Lilly appealed the August 2010 ruling by the District Court of New Jersey that invalidated the method-of-treatment patent protecting atomoxetine (U.S. Pat. No. 5,658,590), the active ingredient in Strattera. The patent is set to expire in May 2017. The appeal hearing was held on 9 December 2010, and a decision is expected at any time. An injunction pending the appeal is in effect. Our valuation of $35.00 is derived by placing our 2012E EPS estimate on a circa 25% discount to the 2012E US market PE multiple. Risks: Patent expiries/ challenges; cost saving; acquisitions; R&D risk; manufacturing; reimbursement; product litigation/ withdrawal
 






Anonymous said:
Primary Care Reps should have it pulled. We should have a specialty rep calling on high writters in PC and Pedi offices. In fact, that person should cover high Psych customers. Think about it... 400 dollars to make a call and if you were a business owner you would not let us call on these useless pedi's.even if they are an easy call and are the only customers who will see us.
Click to expand...

What actually defines a high prescriber of Strattera?
 






psych reps are taking over Strattera in July. Finally sending in the true sales people within the company to get Strattera to its potential. To bad we had shitty primary care rep's that dont think for themselves holding this drug back since launch. Hopefully its not to late to grow Strattera to a billion dollar plus brand!
 






Anonymous said:
psych reps are taking over Strattera in July. Finally sending in the true sales people within the company to get Strattera to its potential. To bad we had shitty primary care rep's that dont think for themselves holding this drug back since launch. Hopefully its not to late to grow Strattera to a billion dollar plus brand!
Click to expand...

Wrong. I asked a doc once, could it be that I HAVE ADD? He just shook his head, and said, those who have it are already gone.
 












Anonymous said:
psych reps are taking over Strattera in July. Finally sending in the true sales people within the company to get Strattera to its potential. To bad we had shitty primary care rep's that dont think for themselves holding this drug back since launch. Hopefully its not to late to grow Strattera to a billion dollar plus brand!
Click to expand...

Now that is funny!
 






Doesn't surprise me that Psych rep's got Strattera. It is well known that the best talent in our sales force resides in the NSR group- I don't agree with it but that is the general feeling.
 












Anonymous said:
Doesn't surprise me that Psych rep's got Strattera. It is well known that the best talent in our sales force resides in the NSR group- I don't agree with it but that is the general feeling.
Click to expand...

I suppose we can expect a 20% increase in Strattera prescriptions over the next 12 months with our elite psych force calling on the customers!
 






Anonymous said:
psych reps are taking over Strattera in July. Finally sending in the true sales people within the company to get Strattera to its potential. To bad we had shitty primary care rep's that dont think for themselves holding this drug back since launch. Hopefully its not to late to grow Strattera to a billion dollar plus brand!
Click to expand...





primary care reps can figure out the proper use of to vs. too, its vs. it's. Way to go you specialist you.
 
























Top Bottom
Back
Quote